Follow
'Immunotherapy provides a striking example of a rare success in treating advanced cancer, as seen in a substantial fraction of patients with metastatic melanoma and in some patients with lung and renal cancer resistance. But resistance can and does arise via immune editing as seen with human leukocyte antigens (HLA) loss in lung cancer consequent to the selective pressure from endogenous immune surveillance'
